A critical advance in cancer study is emerging with the use of VHH fragments to reactivate damaged p53. This crucial cancer protector protein is frequently inactivated in many types of tumors, leading uncontrolled https://socialnetworkadsinfo.com/story23690433/mini-antibodies-reactivate-the-p53-protein-a-promising-pathway-for-cancer-therapy